diclofenac has been researched along with Facial Dermatoses in 7 studies
Diclofenac: A non-steroidal anti-inflammatory agent (NSAID) with antipyretic and analgesic actions. It is primarily available as the sodium salt.
diclofenac : A monocarboxylic acid consisting of phenylacetic acid having a (2,6-dichlorophenyl)amino group at the 2-position.
Facial Dermatoses: Skin diseases involving the FACE.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Ingenol mebutate (IngMeb) and diclofenac sodium (DS) are approved treatments for actinic keratosis (AK)." | 9.27 | Phase IV head-to-head randomized controlled trial comparing ingenol mebutate 0·015% gel with diclofenac sodium 3% gel for the treatment of actinic keratosis on the face or scalp. ( Harwood, CA; Larsson, T; Serra-Guillén, C; Skov, T; Stockfleth, E; Østerdal, ML, 2018) |
| "Ingenol mebutate (IngMeb) and diclofenac sodium (DS) are approved treatments for actinic keratosis (AK)." | 5.27 | Phase IV head-to-head randomized controlled trial comparing ingenol mebutate 0·015% gel with diclofenac sodium 3% gel for the treatment of actinic keratosis on the face or scalp. ( Harwood, CA; Larsson, T; Serra-Guillén, C; Skov, T; Stockfleth, E; Østerdal, ML, 2018) |
| "Acute generalized exanthematic pustulosis (AGEP) is characterized by a generalized rash and sterile disseminated, sometimes coalescing subcorneal pustules." | 1.33 | [Acute localized exanthematous pustulosis (ALEP)]. ( Hengge, UR; Hodzic-Avdagic, N; Kalke, A; Marini, A; Prange, B; Ruzicka, T, 2005) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (14.29) | 18.2507 |
| 2000's | 3 (42.86) | 29.6817 |
| 2010's | 2 (28.57) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Beutner, C | 1 |
| Forkel, S | 1 |
| Kreipe, K | 1 |
| Geier, J | 1 |
| Buhl, T | 1 |
| Stockfleth, E | 1 |
| Harwood, CA | 1 |
| Serra-Guillén, C | 1 |
| Larsson, T | 1 |
| Østerdal, ML | 1 |
| Skov, T | 1 |
| Zane, C | 1 |
| Facchinetti, E | 1 |
| Rossi, MT | 1 |
| Specchia, C | 1 |
| Calzavara-Pinton, PG | 1 |
| Gebauer, K | 1 |
| Brown, P | 1 |
| Varigos, G | 1 |
| Prange, B | 1 |
| Marini, A | 1 |
| Kalke, A | 1 |
| Hodzic-Avdagic, N | 1 |
| Ruzicka, T | 1 |
| Hengge, UR | 1 |
| Smith, SR | 1 |
| Morhenn, VB | 1 |
| Piacquadio, DJ | 1 |
| Dhar, S | 1 |
| Kanwar, AJ | 1 |
| Dawn, G | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Efficacy and Safety of Ingenol Mebutate Gel 0.015% Compared to Diclofenac Sodium Gel 3% in Subjects With Actinic Keratoses on the Face or Scalp[NCT02406014] | Phase 4 | 502 participants (Actual) | Interventional | 2015-04-30 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
4 trials available for diclofenac and Facial Dermatoses
| Article | Year |
|---|---|
Phase IV head-to-head randomized controlled trial comparing ingenol mebutate 0·015% gel with diclofenac sodium 3% gel for the treatment of actinic keratosis on the face or scalp.
Topics: Administration, Cutaneous; Adult; Aged; Aged, 80 and over; Dermatologic Agents; Diclofenac; Diterpen | 2018 |
A randomized clinical trial of photodynamic therapy with methyl aminolaevulinate vs. diclofenac 3% plus hyaluronic acid gel for the treatment of multiple actinic keratoses of the face and scalp.
Topics: Adult; Aged; Aged, 80 and over; Aminolevulinic Acid; Cost-Benefit Analysis; Diclofenac; Drug Combina | 2014 |
Topical diclofenac in hyaluronan gel for the treatment of solar keratoses.
Topics: Administration, Cutaneous; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; | 2003 |
Bilateral comparison of the efficacy and tolerability of 3% diclofenac sodium gel and 5% 5-fluorouracil cream in the treatment of actinic keratoses of the face and scalp.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antimetabolites, Antineoplastic; Diclofenac; Facial Dermato | 2006 |
3 other studies available for diclofenac and Facial Dermatoses
| Article | Year |
|---|---|
Contact allergy to topical diclofenac with systemic tolerance.
Topics: Administration, Oral; Administration, Topical; Aged, 80 and over; Anti-Inflammatory Agents, Non-Ster | 2022 |
[Acute localized exanthematous pustulosis (ALEP)].
Topics: Acute Disease; Anti-Inflammatory Agents, Non-Steroidal; Diagnosis, Differential; Diclofenac; Drug Er | 2005 |
Localization of drug rash over the sites of neuralgia.
Topics: Ampicillin; Diclofenac; Drug Eruptions; Erythema Multiforme; Facial Dermatoses; Humans; Leg Dermatos | 1995 |